154 related articles for article (PubMed ID: 2278875)
1. Sotalol in patients with life-threatening ventricular tachyarrhythmias.
Trappe HJ; Klein H; Lichtlen P
Cardiovasc Drugs Ther; 1990 Oct; 4(5):1425-32. PubMed ID: 2278875
[TBL] [Abstract][Full Text] [Related]
2. [Antiarrhythmia effectiveness of oral sotalol in patients with coronary heart disease and ventricular tachycardias].
Trappe HJ; Klein H; Lichtlen PR
Z Kardiol; 1987 Oct; 76(10):630-4. PubMed ID: 3687165
[TBL] [Abstract][Full Text] [Related]
3. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.
Kühlkamp V; Mewis C; Mermi J; Bosch RF; Seipel L
J Am Coll Cardiol; 1999 Jan; 33(1):46-52. PubMed ID: 9935007
[TBL] [Abstract][Full Text] [Related]
4. Infarct related artery patency: relation to serial electropharmacological studies and outcome in patients with previous myocardial infarction and ventricular tachyarrhythmias.
Hoppe UC; Haverkamp W; Breithardt G; Borggrefe M
Pacing Clin Electrophysiol; 2000 May; 23(5):854-62. PubMed ID: 10833706
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.
Kuchar DL; Garan H; Venditti FJ; Finkelstein D; Rottman JN; McComb J; McGovern BA; Ruskin JN
Am J Cardiol; 1989 Jul; 64(1):33-6. PubMed ID: 2741811
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.
Haverkamp W; Martinez-Rubio A; Hief C; Lammers A; Mühlenkamp S; Wichter T; Breithardt G; Borggrefe M
J Am Coll Cardiol; 1997 Aug; 30(2):487-95. PubMed ID: 9247523
[TBL] [Abstract][Full Text] [Related]
7. Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents.
Nademanee K; Singh BN
Am J Cardiol; 1990 Jan; 65(2):53A-57A; discussion 65A-66A. PubMed ID: 2403735
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
Steinbeck G; Bach P; Haberl R
J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
[TBL] [Abstract][Full Text] [Related]
9. Long-term reproducibility of electrophysiologically guided therapy with sotalol in patients with ventricular tachyarrhythmias.
Mewis C; Kühlkamp V; Mermi J; Bosch RF; Seipel L
J Am Coll Cardiol; 1999 Jun; 33(7):1989-95. PubMed ID: 10362204
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
Kühlkamp V; Mermi J; Mewis C; Seipel L
J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy of d/l sotalol in patients with sustained ventricular tachycardia refractory to class I antiarrhythmic drugs.
Kühlkamp V; Mermi J; Mewis C; Braun U; Seipel L
Eur Heart J; 1995 Nov; 16(11):1625-31. PubMed ID: 8881857
[TBL] [Abstract][Full Text] [Related]
12. [Ventricular tachycardia and ventricular fibrillation following myocardial infarct: determinants of prognosis and disease course].
Trappe HJ; Brugada P; Talajic M; Lezaun R; Wellens HJ
Z Kardiol; 1988 Nov; 77(11):687-95. PubMed ID: 3213136
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of sotalol guided by programmed electrical stimulation for sustained ventricular arrhythmias secondary to coronary artery disease.
Young GD; Kerr CR; Mohama R; Boone J; Yeung-Lai-Wah JA
Am J Cardiol; 1994 Apr; 73(9):677-82. PubMed ID: 8166065
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias.
Nademanee K; Feld G; Hendrickson J; Singh PN; Singh BN
Circulation; 1985 Sep; 72(3):555-64. PubMed ID: 4017207
[TBL] [Abstract][Full Text] [Related]
15. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
[TBL] [Abstract][Full Text] [Related]
16. Low-dose oral sotalol for monomorphic ventricular tachycardia: effects during programmed electrical stimulation and follow-up.
Jordaens LJ; Palmer A; Clement DL
Eur Heart J; 1989 Mar; 10(3):218-26. PubMed ID: 2707270
[TBL] [Abstract][Full Text] [Related]
17. Comparison of d,l-sotalol and implantable defibrillators for treatment of sustained ventricular tachycardia or fibrillation in patients with coronary artery disease.
Böcker D; Haverkamp W; Block M; Borggrefe M; Hammel D; Breithardt G
Circulation; 1996 Jul; 94(2):151-7. PubMed ID: 8674173
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of sotalol for drug-refractory malignant ventricular arrhythmias.
Gonzalez R; Scheinman MM; Herre JM; Griffin JC; Sauve MJ; Sharkey H
J Am Coll Cardiol; 1988 Dec; 12(6):1568-72. PubMed ID: 3192854
[TBL] [Abstract][Full Text] [Related]
19. Practical considerations in the use of sotalol for ventricular tachycardia and ventricular fibrillation.
Campbell RW; Furniss SS
Am J Cardiol; 1993 Aug; 72(4):80A-85A. PubMed ID: 8346732
[TBL] [Abstract][Full Text] [Related]
20. How to evaluate class III antiarrhythmic drug efficacy clinically: the benefits and shortcomings of the invasive approach.
Borggrefe M; Haverkamp W; Shenasa M; Hindricks G; Breithardt G
J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S32-40. PubMed ID: 1279307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
